Koning E

Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada.

7 papers · 1 preprint · ORCID

ArticlePsilocybin

Psilocybin as a Transdiagnostic Treatment for Eating Disorders and Comorbid Psychopathology: Implications for Clinical Nosology and Research Directions.

Koning E, Richard J, Keshen A

Europe PMC2026
ArticlePsilocybin

Psilocybin Treatment as an Adjunct to Cognitive Behavioral Therapy for Eating Disorders: Therapeutic Rationale & Considerations for Protocol Development.

Koning E, Gamberg S, Keshen A

Europe PMC2026
PreprintPsilocybin

Psilocybin Treatment as an Adjunct to Cognitive Behavioral Therapy for Eating Disorders: Therapeutic Rationale & Considerations for Protocol Development

Koning E, Gamberg S, Keshen A

Europe PMC2025
ArticlePsilocybin

Which Psychotherapy Model Should be Used in Psilocybin Treatment for Depression?

Koning E, Bacchi P, Chaves C +2

Europe PMC2025
ArticlePsychedelics

Why psychedelic-assisted therapy studies in eating disorders risk missing the mark on outcomes: a phenomenological psychopathology perspective.

Koning E, McMillan RM, Keshen A +4

Europe PMC2025
ArticlePsilocybin

Exploring the neurobiological correlates of psilocybin-assisted psychotherapy in eating disorders: a review of potential methodologies and implications for the psychedelic study design.

Koning E, Chaves C, Kirkpatrick RH +1

Europe PMC2024
ArticlePsychedelics

The influence of stakeholder interests on safety outcome reporting in psychedelic research and implications for science communication.

Koning E, Solmi M, Brietzke E

Europe PMC2025
ArticlePsilocybin

Psilocybin-assisted psychotherapy as a potential treatment for eating disorders: a narrative review of preliminary evidence.

Koning E, Brietzke E

Europe PMC2024